Karissa Waddick
EditorKarissa Waddick is an editor for PharmaVoice. She most recently covered the ins and outs of workplace safety and health policy for Inside Washington Publishers, writing about federal and local COVID-19 vaccine regulations. Prior to that role, she helped build a database of need-to-know policy and business influencer profiles at National Journal. Though a Boston-area native, Karissa moved to the Washington, D.C., area to attend American University and has stayed ever since. She is an avid Red Sox fan, amateur photographer and crafting enthusiast.
33 articles by Karissa Waddick
-
Feds could soon bring COVID-style fight to superbug threat
Sept. 13, 2022 -
Entrepreneurs: Jeff Fischer
Sept. 6, 2022 -
Disrupters: Jennifer Gould
Sept. 6, 2022 -
DE&I Champions: Otis Johnson
Sept. 6, 2022 -
Legacy Leaders: Dr. Steven Steinhubl
Sept. 6, 2022 -
Moderna’s lawsuit against Pfizer and BioNTech explained in 10 quotes
Aug. 31, 2022 -
Parexel joins pharmacy giants in quest to boost community health clinical trials
Aug. 30, 2022 -
Moderna, Eli Lilly and Schrödinger seek to boost financial and people strategies with key new hires
Aug. 24, 2022 -
3 ways pharma can prep for Biden’s sweeping drug pricing policies
Aug. 18, 2022 -
The FDA is mulling an OTC approval for a birth control. Will politics factor in?
Aug. 15, 2022 -
Editas, Real Chemistry and Compass blaze new trails with pivotal C-suite hires
Aug. 3, 2022 -
Taking probiotics where they’ve never gone before
Aug. 2, 2022 -
Personalized data could bring PhysIQ to the forefront of clinical trial evolution
July 28, 2022 -
Democrats think they've found a balance between drug innovation and pricing negotiation
July 26, 2022 -
Moderna's next vax target? A little-known cause of birth defects
July 21, 2022 -
By the numbers: The rising danger of superbugs
July 20, 2022 -
Making moves: Agios, BeiGene, Biocom California and more announce new key hires
July 18, 2022 -
Janssen extends LGBTQ mental health outreach beyond Pride Month
July 14, 2022 -
Pharma companies take a fresh approach to inclusion in new DTC ads
July 5, 2022 -
Making moves: Walgreens, Merck, eClinical Solutions and more announce key new hires
June 29, 2022 -
With abortion access restricted across the U.S., a new diagnostic aims to eliminate birth control's pain points
June 28, 2022 -
#DIA2022: Building 'guardrails' in the FDA's accelerated approval program
June 21, 2022 -
TikTok tutorial: How pharma can embrace the video platform's educational potential
June 15, 2022 -
Making moves: Civica, Astellas, Inozyme and more announce key new hires
June 13, 2022 -
Pharma giants take on Appalachian cancer rates in newest screening initiative
June 7, 2022